Wyeth secures Australian injunction against MSD vaccine
30-11-2020
Australian court issues mixed vaccine patent ruling
15-10-2020
Appeals court sides with Pfizer, Merck KGaA in $5bn suit
29-09-2020
Atmosphere1 / Shutterstock.com
The English High Court has concluded that Merck Sharp Dohme (MSD) is not infringing a patent owned by Pfizer through the sale of its pneumococcal conjugate vaccine.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
MSD, Merck Sharp Dohme, Wyeth, Pfizer, vaccine, patent infringement, patent invalidity, English High Court
